Product image of Aranesp (Darbepoetin Alfa) supplied by GNH India

Aranesp

Active Ingredient:
Darbepoetin Alfa
Origin:
EU

Aranesp (Darbepoetin Alfa)

Aranesp (Darbepoetin Alfa) is a medication used to treat anemia, particularly in patients with chronic kidney disease. This subcutaneous injection helps stimulate red blood cell production, improving energy levels and reducing fatigue.

Manufacturer / TM Owner

Amgen Europe B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Aranesp is primarily used to manage anemia in patients with chronic kidney disease who are on dialysis or not on dialysis. It works by stimulating the bone marrow to produce more red blood cells, which can help alleviate symptoms of anemia such as fatigue and weakness. The medication is also used in certain cancer patients undergoing chemotherapy to reduce the need for blood transfusions.

Side Effects

  • Common effects of Aranesp may include injection site reactions, such as redness, swelling, or pain. Some patients may experience flu-like symptoms, such as fever, chills, or muscle aches. It is important to discuss any persistent or severe side effects with a healthcare provider.

Precautions & Warnings

  • Aranesp should be used with caution in patients with a history of heart disease, high blood pressure, or seizures. It is important to follow the prescribed dosage and administration instructions to minimize the risk of side effects. Regular monitoring of blood cell counts is recommended during treatment.

Avoid Interactions

  • Aranesp may interact with other medications, including those that affect the immune system or blood cell production. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated, as it may affect the overall effectiveness of the treatment.

Frequently Asked Questions

Aranesp is used to treat anemia in patients with chronic kidney disease and in certain cancer patients undergoing chemotherapy.

Aranesp is administered via subcutaneous injection, typically by a healthcare professional.

Common side effects may include injection site reactions, flu-like symptoms, and fatigue.

Aranesp may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

The frequency of Aranesp administration depends on the individual's condition and response to treatment, as determined by a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Darbepoetin Alfa

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT